Statements (51)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:DJ
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:ILMN
|
gptkbp:analysis |
gptkb:Base_Space_Sequence_Hub
|
gptkbp:application |
Cancer research
Microbial genomics Personalized medicine Genomic research |
gptkbp:capacity |
up to 1 billion reads
|
gptkbp:collaborations |
Various research institutions
|
gptkbp:competitors |
gptkb:Pacific_Biosciences
gptkb:Ion_Torrent 454 Life Sciences |
gptkbp:developed_by |
gptkb:Illumina,_Inc.
|
gptkbp:economic_impact |
Revolutionized genomics
|
https://www.w3.org/2000/01/rdf-schema#label |
Illumina Genome Analyzer
|
gptkbp:impact |
Contributed to the Human Genome Project
Improved diagnostics Accelerated genomic discoveries Advanced transcriptomics research Contributed to evolutionary biology studies Enabled pharmacogenomics studies Enabled population genomics Enhanced forensic genomics Enhanced understanding of genetic diseases Facilitated large-scale studies Facilitated synthetic biology applications Promoted epigenomics research Supported agricultural genomics Supported metagenomics studies |
gptkbp:input_output |
gptkb:FASTQ
Raw sequencing data Aligned reads Variant calls |
gptkbp:length |
up to 100 base pairs
|
gptkbp:library |
Fragmentation and adapter ligation
|
gptkbp:performance |
High accuracy
|
gptkbp:platform |
Benchtop sequencer
|
gptkbp:price |
Lowered cost of sequencing
|
gptkbp:recorded_by |
gptkb:DJ
gptkb:CEO c DNA |
gptkbp:regulatory_compliance |
FDA approved for clinical use
|
gptkbp:release_year |
gptkb:2006
|
gptkbp:seed_dispersal |
Paired-end sequencing
Single-end sequencing |
gptkbp:successor |
Illumina Hi Seq
Illumina Next Seq Illumina Nova Seq |
gptkbp:technology |
Sequencing by synthesis
|
gptkbp:user_base |
Widely used in laboratories
|